Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization - PubMed (original) (raw)
Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization
P Carmeliet et al. J Clin Invest. 1993 Dec.
Abstract
Homozygous plasminogen activator inhibitor-1 (PAI-1)-deficient (PAI-1-/-) mice were generated by homologous recombination in D3 embryonic stem cells. Deletion of the genomic sequences encompassing the transcription initiation site and the entire coding regions of murine PAI-1 was demonstrated by Southern blot analysis. A 3.0-kb PAI-1-specific mRNA was identified by Northern blot analysis in liver from PAI-1 wild type (PAI-1+/+) but not from PAI-1-/- mice. Plasma PAI-1 levels, measured 2-4 h after endotoxin (2.0 mg/kg) injection were 63 +/- 2 ng/ml, 30 +/- 10 ng/ml, and undetectable (< 2 ng/ml) in PAI-1+/+, heterozygous (PAI-1+/-) and PAI-1-/- mice, respectively (mean +/- SEM, n = 4-11). PAI-1-specific immunoreactivity was demonstrable in kidneys of PAI-1+/+ but not of PAI-1-/- mice. SDS-gel electrophoresis of plasma incubated with 125I-labeled recombinant human tissue-type plasminogen activator revealed an approximately 115,000-M(r) component with plasma from endotoxin-stimulated (0.5 mg/kg) PAI-1+/+ but not from PAI-1-/- mice, which could be precipitated with a polyclonal anti-PAI-1 antiserum. PAI-1-/- mice were viable, produced similar sizes of litters as PAI-1+/+ mice, and showed no apparent macroscopic or microscopic histological abnormalities.
Similar articles
- Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice.
Lijnen HR, Moons L, Beelen V, Carmelie P, Collen D. Lijnen HR, et al. Thromb Haemost. 1995 Oct;74(4):1126-31. Thromb Haemost. 1995. PMID: 8560424 - Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
Bijnens AP, Knockaert I, Cousin E, Kruithof EK, Declerck PJ. Bijnens AP, et al. Thromb Haemost. 1997 Feb;77(2):350-6. Thromb Haemost. 1997. PMID: 9157595 - Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.
Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D. Carmeliet P, et al. J Clin Invest. 1993 Dec;92(6):2756-60. doi: 10.1172/JCI116893. J Clin Invest. 1993. PMID: 8254029 Free PMC article. - Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.
Dewerchin M, Collen D, Lijnen HR. Dewerchin M, et al. Thromb Haemost. 2001 Aug;86(2):640-6. Thromb Haemost. 2001. PMID: 11522016 - Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM, Providence KM, Higgins PJ. Kutz SM, et al. Cell Motil Cytoskeleton. 2001 Mar;48(3):163-74. doi: 10.1002/1097-0169(200103)48:3<163::AID-CM1006>3.0.CO;2-C. Cell Motil Cytoskeleton. 2001. PMID: 11223948
Cited by
- Inhibitory Monoclonal Antibodies against Mouse Proteases Raised in Gene-Deficient Mice Block Proteolytic Functions in vivo.
Lund IK, Rasch MG, Ingvarsen S, Pass J, Madsen DH, Engelholm LH, Behrendt N, Høyer-Hansen G. Lund IK, et al. Front Pharmacol. 2012 Jun 28;3:122. doi: 10.3389/fphar.2012.00122. eCollection 2012. Front Pharmacol. 2012. PMID: 22754528 Free PMC article. - Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease.
Liu RM, van Groen T, Katre A, Cao D, Kadisha I, Ballinger C, Wang L, Carroll SL, Li L. Liu RM, et al. Neurobiol Aging. 2011 Jun;32(6):1079-89. doi: 10.1016/j.neurobiolaging.2009.06.003. Epub 2009 Jul 14. Neurobiol Aging. 2011. PMID: 19604604 Free PMC article. - The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.
Courey AJ, Horowitz JC, Kim KK, Koh TJ, Novak ML, Subbotina N, Warnock M, Xue B, Cunningham AK, Lin Y, Goldklang MP, Simon RH, Lawrence DA, Sisson TH. Courey AJ, et al. Blood. 2011 Aug 25;118(8):2313-21. doi: 10.1182/blood-2010-12-324574. Epub 2011 Jul 6. Blood. 2011. PMID: 21734232 Free PMC article. - PAI-1 Regulates the Cytoskeleton and Intrinsic Stiffness of Vascular Smooth Muscle Cells.
Khoukaz HB, Vadali M, Schoenherr A, Ramirez-Perez FI, Morales-Quinones M, Sun Z, Fujie S, Foote CA, Lyu Z, Zeng S, Augenreich MA, Cai D, Chen SY, Joshi T, Ji Y, Hill MA, Martinez-Lemus LA, Fay WP. Khoukaz HB, et al. Arterioscler Thromb Vasc Biol. 2024 Oct;44(10):2191-2203. doi: 10.1161/ATVBAHA.124.320938. Epub 2024 Jun 13. Arterioscler Thromb Vasc Biol. 2024. PMID: 38868940 - The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies.
Bajou K, Masson V, Gerard RD, Schmitt PM, Albert V, Praus M, Lund LR, Frandsen TL, Brunner N, Dano K, Fusenig NE, Weidle U, Carmeliet G, Loskutoff D, Collen D, Carmeliet P, Foidart JM, Noël A. Bajou K, et al. J Cell Biol. 2001 Feb 19;152(4):777-84. doi: 10.1083/jcb.152.4.777. J Cell Biol. 2001. PMID: 11266468 Free PMC article.
References
- Cell. 1976 Oct;9(2):231-40 - PubMed
- J Clin Invest. 1993 Dec;92(6):2756-60 - PubMed
- Thromb Haemost. 1984 Jul 29;51(3):392-5 - PubMed
- J Embryol Exp Morphol. 1985 Jun;87:27-45 - PubMed
- J Biol Chem. 1985 Sep 25;260(21):11581-7 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous